Category Archives: BioUtah News
Quansys Biosciences launches new NHP line of Multiplex ELISA Assays
NHP-specific ELISAs now available from Quansys Biosciences
UTAH’S LIFE SCIENCES INDUSTRY TAKES TO THE HILL
Utah’s vibrant life sciences industry was on full display January 27 as part of the Governor’s Office of Economic Opportunity “Life Sciences Day on the Hill”. The event, held at the state capitol, provided lawmakers the opportunity to interact one-on-one with leaders from local med tech, biotech and diagnostics companies. More than two dozen companies […]
BIOMERICS COMPLETES CONNECTICUT EXPANSION
SALT LAKE CITY, Jan. 20, 2023 /PRNewswire/ — Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced completion of a 26,000 sq. ft. expansion of its Monroe, CTfacility. The Monroe facility is the headquarters of Biomerics’ micro-metals processing business and specializes in the design, development, and manufacture of complex […]
Intermountain Healthcare is now “Intermountain Health”
Intermountain Healthcare has now officially changed its name to Intermountain Health, reflecting an added emphasis on keeping people healthy, as well as continuing to provide world-class medical care at its hospitals and clinics. Intermountain Health announced the name change in 2022 and that the name would be officially changed in 2023. The name change was […]
DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease
DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease
POSITIVE TWO-YEAR CLINICAL DATA ANNOUNCED FOR STUDY OF DISCOGENIC PROGENITOR CELL THERAPY (IDCT) FOR DEGENERATIVE DISC DISEASE
POSITIVE TWO-YEAR CLINICAL DATA ANNOUNCED FOR STUDY OF DISCOGENIC PROGENITOR CELL THERAPY (IDCT) FOR DEGENERATIVE DISC DISEASE
Renalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United States
Award for consortium of industry, academic and clinical research leaders to develop personalized drug response tests in chronic kidney disease
Halia Therapeutics Appoints Former Amgen Executive, Margit M. Janát-Amsbury, MD, Ph.D., as Chief Medical Officer
Halia Therapeutics announced the appointment of Dr. Margit M. Janát-Amsbury, MD, Ph.D. as the company’s Chief Medical Officer
Advanced Practice Clinical Laboratory Training Center at ARUP Secures $3 Million in Federal Funding
ARUP Laboratories and the University of Utah’s Division of Medical Laboratory Sciences have secured $3 million in federal funding.
Inherent Biosciences Partners With Posterity Health to Accelerate the Path to Parenthood by Elevating the Standard of Care in Male Reproductive Health
Inherent Biosciences has teamed up with Posterity Health, the only virtual Male Fertility Center of Excellence, to address male fertility
Renalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systems
Significant milestone will make KidneyIntelX accessible to 960,000 veterans with chronic kidney disease
Fluidx Unveils New Embolic for Neurovascular Use
New Catheter-Delivered Embolic Shows Promise for Treating Life-Threatening Bleeding around the Brain
